Novel Receptor Antagonists and Their Methods of Use
The present invention relates to novel oxo-prolinamide derivatives of formula (I) which modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration.
-
Page/Page column 15-16
(2008/06/13)
More Articles about upstream products of 1001389-33-8